Last reviewed · How we verify

NCT03957746

Set Volume of Optimal Resistance Exercise to Generate Hypotension

Completed NA Last updated 5 October 2021
What this trial tests

NA trial testing Resistance training in Hypertension in 19 participants. Completed in 3 October 2021.

Timeline
13 May 2020
Primary endpoint
1 October 2020
3 October 2021

Quick facts

Lead sponsorUniversity of Valencia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment19
Start date13 May 2020
Primary completion1 October 2020
Estimated completion3 October 2021
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Valencia

Who can join

Adults 55 to 70, any sex, with Hypertension or Post-Exercise Hypotension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the volume of optimal resistance exercise to generate postexercise hypotension after performing a single exercise in hypertensive elderly subjects. 20 subjects will perform 1 control session and 3 resistance training sessions with different volume: 3, 6 and 9 sets

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Minimal Dose of Resistance Exercise Required to Induce Immediate Hypotension Effect in Older Adults with Hypertension: Randomized Cross-Over Controlled Trial.
    Gargallo P, Casaña J, Suso-Martí L, Cuenca-Martínez F, et al · · 2022 · cited 6× · PMID 36361100 · DOI 10.3390/ijerph192114218

Verify or expand the search:

Other trials of Resistance training

Trials testing the same drug.

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other University of Valencia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03957746.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing